CareFusion To Pay $41M To End Marketing Probe

Law360, New York (April 26, 2013, 7:22 PM EDT) -- CareFusion Corp. on Thursday announced that it will pay $41 million under an agreement in principle with the U.S government to avoid prosecution and resolve investigations related to the sales and marketing practices of its antiseptic medical wipes.

CareFusion, a former Cardinal Health Inc. unit, said the allegations concerned its marketing of ChloraPrep preoperative skin products as well as its relationship with health care professionals. As part of the agreement, CareFusion has entered into a nonprosecution agreement and agreed to cooperate with the government.

"We are...
To view the full article, register now.